• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血脑屏障:对脑肿瘤化疗的影响]

[The blood-brain barrier: implications for chemotherapy in brain tumors].

作者信息

Boaziz C, Breau J L, Morère J F, Israël L

机构信息

Service d'Oncologie Médicale, Hôpital Avicenne, Bobigny, France.

出版信息

Pathol Biol (Paris). 1991 Oct;39(8):789-95.

PMID:1762838
Abstract

The blood-brain barrier (BBB) is located between the blood and the extracellular space of the brain. This barrier is formed by the brain capillaries whose endothelial cells have tight intercellular junctions. Transcellular passage of drugs from the bloodstream to the brain occurs selectively, in a manner dependent on the ability of the molecules to penetrale through cell membranes. The blood-brain barrier is one of the main factors of chemotherapy failure in central nervous system tumors. Penetration of a molecule from the bloodstream to the brain is dependent on the compound's liposolubility, expressed by the octanol-water separation coefficient. Following intravenous administration, most drugs fail to achieve adequate levels in the central nervous system for a sufficiently long period of time. A variety of techniques have been used in an attempt to increase CNS penetration of drugs normally shut out by the blood-brain barrier: high-dose chemotherapy, intrathecal injections, intraarterial injections, induction of hyperosmolarity to make the blood-brain barrier permeable. The best results are obtained using liposoluble drugs with optimal octanol-water separation coefficients, such as fotemustine. This compound given as single drug therapy in brain metastases from malignant melanomas has yielded response rates of up to 28.2%.

摘要

血脑屏障(BBB)位于血液与脑的细胞外间隙之间。该屏障由脑毛细血管形成,其内皮细胞具有紧密的细胞间连接。药物从血液经细胞转运至脑是选择性发生的,其方式取决于分子穿透细胞膜的能力。血脑屏障是中枢神经系统肿瘤化疗失败的主要因素之一。分子从血液进入脑的穿透取决于化合物的脂溶性,用辛醇 - 水分配系数表示。静脉给药后,大多数药物在足够长的时间内无法在中枢神经系统中达到足够的水平。为了增加通常被血脑屏障阻隔的药物对中枢神经系统的穿透,人们使用了多种技术:大剂量化疗、鞘内注射、动脉内注射、诱导高渗以使血脑屏障通透。使用具有最佳辛醇 - 水分配系数的脂溶性药物可获得最佳效果,如福莫司汀。这种化合物在恶性黑色素瘤脑转移中作为单一药物治疗,有效率高达28.2%。

相似文献

1
[The blood-brain barrier: implications for chemotherapy in brain tumors].[血脑屏障:对脑肿瘤化疗的影响]
Pathol Biol (Paris). 1991 Oct;39(8):789-95.
2
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.通过动脉内输注和破坏血脑屏障增强恶性脑肿瘤的化疗给药:舍布鲁克的经验。
Cancer. 2005 Jun 15;103(12):2606-15. doi: 10.1002/cncr.21112.
3
[Brain metastases of malignant melanomas].[恶性黑色素瘤的脑转移]
Bull Cancer. 1991;78(4):347-53.
4
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].[恶性胶质瘤化疗中血脑屏障的可逆性开放]
Wien Klin Wochenschr. 1987 May 29;99(11):385-8.
5
Blood-brain barrier and treatment of central nervous system tumors.血脑屏障与中枢神经系统肿瘤的治疗
J Fla Med Assoc. 1992 Oct;79(10):707-10.
6
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.脑淋巴瘤患者经渗透性血脑屏障破坏后脑脊液和血清中甲氨蝶呤的药代动力学
Clin Pharmacol Ther. 2000 Jun;67(6):631-41. doi: 10.1067/mcp.2000.106932.
7
Blood-brain barrier and chemotherapeutic treatment of brain tumors.血脑屏障与脑肿瘤的化疗治疗
Expert Rev Neurother. 2006 Aug;6(8):1199-209. doi: 10.1586/14737175.6.8.1199.
8
[Pharmacologic bases of chemotherapy of brain tumors in children].[儿童脑肿瘤化疗的药理学基础]
Bull Cancer. 1990;77(7):699-713.
9
Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.恶性脑肿瘤化疗中血脑屏障的改变
Fed Proc. 1984 Feb;43(2):214-9.
10
[Clinical significance of mustoforan in management of malignant glioma].[Mustoforan在恶性胶质瘤治疗中的临床意义]
Vopr Onkol. 2007;53(6):724-9.

引用本文的文献

1
Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis.颅脑手术后单发乳腺癌脑转移患者的全身治疗。
Breast Cancer Res Treat. 2020 Feb;180(1):147-155. doi: 10.1007/s10549-020-05531-7. Epub 2020 Jan 17.
2
Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder.
J Neurooncol. 2003 May;63(1):63-7. doi: 10.1023/a:1023781604980.
3
Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.P-糖蛋白的抑制作用:通过血脑屏障体外模型快速评估其对血脑屏障完整性及药物向脑内转运的影响
Pharm Res. 1998 Jul;15(7):993-1000. doi: 10.1023/a:1011913723928.